The burgeoning landscape of innovative treatments for weight management has seen the rise of both glp-3 retatrutide and tirzepatide, both dual mechanism agonists targeting the GLP-1 and GIP receptors. While sharing a comparable therapeutic goal – improving glycemic control and promoting considerable weight reduction – they exhibit intriguing co… Read More